4//SEC Filing
Russell Angus C. 4
Accession 0001479290-21-000173
CIK 0001479290other
Filed
Dec 14, 7:00 PM ET
Accepted
Dec 15, 8:17 PM ET
Size
5.0 KB
Accession
0001479290-21-000173
Insider Transaction Report
Form 4
Russell Angus C.
Director
Transactions
- Purchase
Common Stock
2021-12-13$15.74/sh+6,400$100,741→ 26,913 total
Footnotes (1)
- [F1]The price reported in Table 1, Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $15.65 to $15.81. Mr. Russell undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
Documents
Issuer
Revance Therapeutics, Inc.
CIK 0001479290
Entity typeother
Related Parties
1- filerCIK 0001534002
Filing Metadata
- Form type
- 4
- Filed
- Dec 14, 7:00 PM ET
- Accepted
- Dec 15, 8:17 PM ET
- Size
- 5.0 KB